ClinicalTrials.gg
RecruitingNCT07855367Updated Oct 2, 2026

Cryoneurolysis Versus Bipolar Radiofrequency Ablation of Genicular Nerves for Pain Relief in Symptomatic Knee Osteoarthritis

An interventional study of Ultrasound-guided cryoneurolysis and Bipolar radiofrequency ablation in Cryoneurolysis, Bipolar Radiofrequency Ablation and Genicular Nerves, sponsored by National Cancer Institute, Egypt. Recruiting at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by National Cancer Institute, Egypt · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 2, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.

Planned enrollment
76th of 83
30 · median 62
Started
2026
with 14 others
No phase
76 of 91
22 open now
Primary completion
2027-03
later than 25 of 33 live
Registered
88th of 91
by date

Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 76th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 25 of the 33 other live ones, and was the 88th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Osteoarthritis, Knee with a site in Egypt, or all of them as a file.
02

Study summary

This study aims to compare the reduction in knee pain between ultrasound-guided cryoneurolysis and bipolar radiofrequency ablation (RFA), as measured by the Numerical Rating Scale (NRS) at predefined follow-up intervals.

Read the detailed description

Knee osteoarthritis (KOA) is a major cause of chronic pain and disability worldwide. Pain in knee osteoarthritis is multifactorial and does not always correlate with the degree of radiographic degeneration. In addition to structural joint changes, pain results from synovial inflammation, subchondral bone remodeling, periosteal irritation, ligamentous stress, and sensitization of peripheral and central nociceptive pathways.

Among the available interventional approaches, radiofrequency ablation (RFA) and cryoneurolysis have gained increasing attention because they interrupt pain transmission without affecting joint stability. Radiofrequency ablation (RFA) and cryoneurolysis are two emerging techniques that modulate pain transmission pathways. Bipolar radiofrequency ablation uses thermal energy delivered between two closely positioned electrodes to create a larger and more continuous lesion than conventional monopolar RFA.

03

Conditions studied

  • Cryoneurolysis
  • Bipolar Radiofrequency Ablation
  • Genicular Nerves
  • Pain Relief
  • Symptomatic
  • Knee Osteoarthritis
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 40 years
  • Symptomatic knee osteoarthritis (OA) in bladder cancer patient [based on American College of Radiology (ACR) criteria]
  • Radiological OA (Kellgren-Lawrence grade III-IV)
  • Chronic knee pain ≥ 3-6 months
  • Numerical Rating Scale (NRS) ≥ 5 despite conservative treatment
  • Positive diagnostic genicular nerve block (>50% pain relief).

Exclusion criteria

Exclusion Criteria:

  • Prior genicular nerve ablation
  • Coagulopathy
  • Local infection
  • Severe deformity
  • Neuropathic pain syndromes
  • Uncontrolled comorbidities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Cryoneurolysis group

    Patients will undergo ultrasound-guided cryoneurolysis

    Procedure: Ultrasound-guided cryoneurolysis

  • Experimental
    Radiofrequency ablation group

    Patients will undergo bipolar radiofrequency ablation

    Procedure: Bipolar radiofrequency ablation

Interventions

  • ProcedureUltrasound-guided cryoneurolysis

    Patients will undergo ultrasound-guided cryoneurolysis

  • ProcedureBipolar radiofrequency ablation

    Patients will undergo bipolar radiofrequency ablation

06

What researchers measure

Primary outcomes

  1. Degree of pain

    Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable").

    Time frame: 6 months after procedure

Secondary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score

    Knee Injury and Osteoarthritis Outcome Score (KOOS) will measure * Pain * Symptoms * Activities of daily living * Sports/recreation * Quality of life

    Time frame: 6 months after procedure

  2. Western Ontario and McMaster Universities Osteoarthritis Index

    Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index is a widely used, self-administered questionnaire that evaluates pain, stiffness, and physical function in patients with knee and hip osteoarthritis.

    Time frame: 6 months after procedure

  3. Oxford Knee Score

    The Oxford Knee Score is a 12-item patient-reported questionnaire used to assess pain and physical function in the knee. Score Interpretation 0 to 19 (Severe): May indicate severe knee problems or advanced arthritis; surgical intervention like a knee replacement may be considered. 20 to 29 (Moderate to Severe): Reflects considerable pain and functional limitations. 30 to 39 (Mild to Moderate): Suggests mild-to-moderate joint issues with some activity limitations. 40 to 48 (Satisfactory): Indicates normal or satisfactory joint function with minimal knee problems.

    Time frame: 6 months after procedure

  4. Patient Global Impression of Change (PGIC)

    The traditional Patient Global Impression of Change (PGIC) uses a 7-point scale where patients select the statement that best describes their current state compared to how they felt before treatment: 1. Very much improved (or Much better) 2. Much improved 3. Minimally improved 4. No change (or The same) 5. Minimally worse 6. Much worse 7. Very much worse (or Very much worse)

    Time frame: 6 months after procedure

  5. Measurement of quality of life

    Quality of life will be assessed using EuroQol 5-Dimension 5-Level (EQ-5D-5L).

    Time frame: 6 months after procedure

  6. Total analgesic consumption

    Total analgesic consumption will be recorded.

    Time frame: 24 hours after procedure

  7. Incidence of complication

    Incidence of complication will be recorded.

    Time frame: 24 hours after procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 6 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 2, 2026
StartActual
Sep 15, 2026
Primary completionEst.
Mar 15, 2027
CompletionEst.
Mar 15, 2027
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07855367
Responsible party
Ahmed Salah Ahmed Abd Elgalil (Associate Professor of Anaesthesia and Pain Medicine National Cancer, Cairo University., National Cancer Institute, Egypt) — Principal investigator
First posted
Oct 2, 2026
Start date
Sep 15, 2026
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Oct 2, 2026

Study contacts

Ahmed S Abdelgalil, MD
Contact
ahmed.salah@nci.cu.edu.eg
00201098426689

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion